Updated European Consensus Statement on diagnosis and treatment of adult ADHD
Обновлённое европейское консенсусное заявление по диагностике и лечению СДВГ у взрослых
2018-11-15
SCID: 54.1/h7xbk9ts
Discuss with AI
ADHD diagnosisADHD treatmentEuropean consensus statementadult ADHDlifespan perspective
Figures from the paper
Abstract (AI)
Background Attention-deficit/hyperactivity disorder (ADHD) is among the most common psychiatric disorders of childhood that often persists into adulthood and old age. Yet ADHD is currently underdiagnosed and undertreated in many European countries, leading to chronicity of symptoms and impairment, due to lack of, or ineffective treatment, and higher costs of illness. Methods The European Network Adult ADHD and the Section for Neurodevelopmental Disorders Across the Lifespan (NDAL) of the European Psychiatric Association (EPA), aim to increase awareness and knowledge of adult ADHD in and outside Europe. This Updated European Consensus Statement aims to support clinicians with research evidence and clinical experience from 63 experts of European and other countries in which ADHD in adults is recognized and treated. Results Besides reviewing the latest research on prevalence, persistence, genetics and neurobiology of ADHD, three major questions are addressed: (1) What is the clinical picture of ADHD in adults? (2) How should ADHD be properly diagnosed in adults? (3) How should adult ADHDbe effectively treated? Conclusions ADHD often presents as a lifelong impairing condition. The stigma surrounding ADHD, mainly due to lack of knowledge, increases the suffering of patients. Education on the lifespan perspective, diagnostic assessment, and treatment of ADHD must increase for students of general and mental health, and for psychiatry professionals. Instruments for screening and diagnosis of ADHD in adults are available, as are effective evidence-based treatments for ADHD and its negative outcomes. More research is needed on gender differences, and in older adults with ADHD.
Key Findings
1
ADHD remains substantially underdiagnosed and undertreated across many European countries, contributing to patient suffering and increased illness costs.
2
Adult ADHD commonly persists from childhood into adulthood and older age, often causing lifelong impairment and chronic symptoms.
3
Improved education is needed for healthcare professionals and students, while further research should address gender differences and ADHD in older adults.
4
The consensus statement synthesizes research and clinical expertise from 63 international experts on adult ADHD prevalence, persistence, genetics, neurobiology, diagnosis, and treatment.
5
Validated instruments for screening and diagnosing adult ADHD are available, alongside effective evidence-based treatments for ADHD and its associated negative outcomes.
Research Object
adult attention-deficit/hyperactivity disorder (ADHD)
Research Subject
the clinical presentation, diagnosis, persistence, impairment, and effective treatment of adult ADHD
Publication Details
Publication Date
2018-11-15
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest